268 related articles for article (PubMed ID: 1530850)
1. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
Zimmerman PE; Voelker DR; McCormack FX; Paulsrud JR; Martin WJ
J Clin Invest; 1992 Jan; 89(1):143-9. PubMed ID: 1530850
[TBL] [Abstract][Full Text] [Related]
2. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii.
McCormack FX; Festa AL; Andrews RP; Linke M; Walzer PD
Biochemistry; 1997 Jul; 36(26):8092-9. PubMed ID: 9201957
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A.
Vuk-Pavlovic Z; Standing JE; Crouch EC; Limper AH
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):475-84. PubMed ID: 11306442
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.
O'Riordan DM; Standing JE; Kwon KY; Chang D; Crouch EC; Limper AH
J Clin Invest; 1995 Jun; 95(6):2699-710. PubMed ID: 7769109
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.
Koziel H; Phelps DS; Fishman JA; Armstrong MY; Richards FF; Rose RM
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):834-43. PubMed ID: 9618388
[TBL] [Abstract][Full Text] [Related]
7. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.
Williams MD; Wright JR; March KL; Martin WJ
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):232-8. PubMed ID: 8845173
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice.
Beers MF; Atochina EN; Preston AM; Beck JM
J Lab Clin Med; 1999 May; 133(5):423-33. PubMed ID: 10235125
[TBL] [Abstract][Full Text] [Related]
9. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid.
Sternberg RI; Whitsett JA; Hull WM; Baughman RP
J Lab Clin Med; 1995 Apr; 125(4):462-9. PubMed ID: 7706901
[TBL] [Abstract][Full Text] [Related]
11. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages.
Zhu S; Kachel DL; Martin WJ; Matalon S
Am J Physiol; 1998 Dec; 275(6):L1031-9. PubMed ID: 9843839
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.
Phelps DS; Umstead TM; Rose RM; Fishman JA
Eur Respir J; 1996 Mar; 9(3):565-70. PubMed ID: 8730021
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors.
O'Riordan DM; Standing JE; Limper AH
Infect Immun; 1995 Mar; 63(3):779-84. PubMed ID: 7868247
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages.
Limper AH; Crouch EC; O'Riordan DM; Chang D; Vuk-Pavlovic Z; Standing JE; Kwon KY; Adlakha A
J Lab Clin Med; 1995 Nov; 126(5):416-22. PubMed ID: 7595025
[No Abstract] [Full Text] [Related]
15. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
[TBL] [Abstract][Full Text] [Related]
16. Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour Pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats.
Vives MF; Caspar-Bauguil S; Aliouat EM; Escamilla R; Perret B; Dei-Cas E; Prévost MC
Parasite; 2008 Mar; 15(1):53-64. PubMed ID: 18416247
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein binding to Pneumocystis carinii organisms.
Pottratz ST
J Lab Clin Med; 1995 Nov; 126(5):414-5. PubMed ID: 7595024
[No Abstract] [Full Text] [Related]
18. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
[TBL] [Abstract][Full Text] [Related]
19. Major surface glycoprotein genes from Pneumocystis carinii f. sp. ratti.
Schaffzin JK; Garbe TR; Stringer JR
Fungal Genet Biol; 1999 Dec; 28(3):214-26. PubMed ID: 10669586
[TBL] [Abstract][Full Text] [Related]
20. P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant.
Atochina EN; Beers MF; Scanlon ST; Preston AM; Beck JM
Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L599-609. PubMed ID: 10710533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
